An update on best practice of deep brain stimulation in Parkinson's disease
CJ Hartmann, S Fliegen, SJ Groiss… - Therapeutic …, 2019 - journals.sagepub.com
During the last 30 years, deep brain stimulation (DBS) has evolved into the clinical standard
of care as a highly effective treatment for advanced Parkinson's disease. Careful patient …
of care as a highly effective treatment for advanced Parkinson's disease. Careful patient …
[HTML][HTML] Therapy of Parkinson's disease subtypes
C Marras, KR Chaudhuri, N Titova, TA Mestre - Neurotherapeutics, 2020 - Elsevier
Early descriptions of subtypes of Parkinson's disease (PD) are dominated by the approach
of predetermined groups. Experts defined, from clinical observation, groups based on …
of predetermined groups. Experts defined, from clinical observation, groups based on …
Non-motor outcomes depend on location of neurostimulation in Parkinson's disease
Deep brain stimulation of the subthalamic nucleus is an effective and established therapy for
patients with advanced Parkinson's disease improving quality of life, motor symptoms and …
patients with advanced Parkinson's disease improving quality of life, motor symptoms and …
EuroInf 2: subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease
Objective Real‐life observational report of clinical efficacy of bilateral subthalamic
stimulation (STN‐DBS), apomorphine (APO), and intrajejunal levodopa infusion (IJLI) on …
stimulation (STN‐DBS), apomorphine (APO), and intrajejunal levodopa infusion (IJLI) on …
Neurostimulation for advanced parkinson disease and quality of life at 5 years: a nonrandomized controlled trial
ST Jost, S Aloui, J Evans, K Ashkan… - JAMA network …, 2024 - jamanetwork.com
Importance Deep brain stimulation of the subthalamic nucleus (STN-DBS) improves quality
of life (QOL) in patients with advanced Parkinson disease (PD). However, controlled studies …
of life (QOL) in patients with advanced Parkinson disease (PD). However, controlled studies …
Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease
Background: The objective of this study was to investigate 24‐month of effects of bilateral
subthalamic nucleus (STN) deep brain stimulation (DBS) on nonmotor symptoms in …
subthalamic nucleus (STN) deep brain stimulation (DBS) on nonmotor symptoms in …
Association of subthalamic deep brain stimulation with motor, functional, and pharmacologic outcomes in patients with monogenic Parkinson disease: a systematic …
Importance Comparative outcomes among different monogenic forms of Parkinson disease
after subthalamic nucleus deep brain stimulation (STN DBS) remain unclear. Objective To …
after subthalamic nucleus deep brain stimulation (STN DBS) remain unclear. Objective To …
Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts
Background Subthalamic nucleus (STN) deep brain stimulation (DBS) improves quality of
life (QoL), motor, and non-motor symptoms (NMS) in Parkinson's disease (PD). Few studies …
life (QoL), motor, and non-motor symptoms (NMS) in Parkinson's disease (PD). Few studies …
A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson's disease: results at the 36-month follow-up
ST Jost, A Sauerbier, V Visser-Vandewalle… - Journal of Neurology …, 2020 - jnnp.bmj.com
Objective To examine 36-month effects of bilateral subthalamic nucleus deep brain
stimulation (STN-DBS) on non-motor symptoms (NMS) compared with standard-of-care …
stimulation (STN-DBS) on non-motor symptoms (NMS) compared with standard-of-care …
Update in therapeutic strategies for Parkinson's disease
J Kulisevsky, L Oliveira, SH Fox - Current opinion in neurology, 2018 - journals.lww.com
The motor symptoms of Parkinson's disease can be reasonably treated and managed.
However, therapies to slow or prevent disease progression remain a focus of research …
However, therapies to slow or prevent disease progression remain a focus of research …